What’s Next For Alkermes Stock After A 16% Rise Last Month?
- Thursday, September 2, 2021, 7:12
- Market
- Add a comment
The stock price of Alkermes, a biopharmaceutical company focused on neuroscience and oncology, has seen a rise of around 16% over the last twenty-one trading days, and it is up a solid 91% over the last twelve-month period. The rally in ALKS stock over the recent months has been propelled by the…
About the Author
admin123 has written 23527 stories on this site.
